The systemic inflammatory response is a prognostic marker in human immunodeficiency virus-infected patients with hepatocellular carcinoma

被引:0
|
作者
Pinato, D. J. [1 ]
Merli, M. [2 ]
Pria, A. D. [3 ]
Jamshaid, S. [1 ]
Parker, K. [3 ]
Pagani, N. [3 ]
Hasson, H. [2 ]
Uberti-Foppa, C. [2 ]
Messina, E. [2 ]
Sharma, R. [1 ]
Nelson, M. [3 ]
Bower, M. [3 ]
机构
[1] Imperial Coll London, Surg & Canc, London, England
[2] IRCCS Osped San Raffaele, Infect Dis, Milan, Italy
[3] Chelsea & Westminster NHS Trust, Natl Ctr HIV Malignancy, London, England
关键词
D O I
10.1016/S0168-8278(17)30707-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
THU-069
引用
收藏
页码:S205 / S206
页数:2
相关论文
共 50 条
  • [1] Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients
    Bruno, R
    Puoti, M
    Sacchi, P
    Filice, C
    Carosi, G
    Filice, G
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S146 - S150
  • [2] Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients
    Gramenzi, Annagiulia
    Tedeschi, Sara
    Cantarini, Maria Chiara
    Erroi, Virginia
    Tumietto, Fabio
    Attard, Luciano
    Calza, Leonardo
    Foschi, Francesco Giuseppe
    Caraceni, Paolo
    Pavoni, Michele
    Cucchetti, Alessandro
    Bernardi, Mauro
    Viale, Pierluigi
    Verucchi, Gabriella
    Trevisani, Franco
    [J]. DIGESTIVE AND LIVER DISEASE, 2013, 45 (06) : 516 - 522
  • [3] The systemic inflammatory response is a prognostic marker in HIV-infected patients with hepatocellular carcinoma
    Pinato, D.
    Pria, A. D.
    Parker, K.
    Nelson, M.
    Bower, M.
    [J]. HIV MEDICINE, 2016, 17 : 50 - 50
  • [4] Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular Carcinoma
    Pinato, David J.
    Merli, Marco
    Pria, Alessia Dalla
    Jamshaid, Shiraz
    Parker, Kizzy
    Pagani, Nicole
    Hasson, Hamid
    Foppa, Caterina Uberti
    Messina, Emanuela
    Sharma, Rohini
    Nelson, Mark
    Bower, Mark
    [J]. ONCOLOGY, 2017, 93 (06) : 395 - 400
  • [5] Liver transplantation for human immunodeficiency virus-Infected patients with hepatocellular carcinoma
    Citti, C.
    Pinato, D.
    Ventura-Cots, M.
    Platt, H.
    Merli, M.
    Minguez, B.
    Pria, A. D.
    Sharma, R.
    Marcus, S.
    Nelson, M.
    Bower, M.
    Mazzaferro, V.
    Brau, N.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S216 - S216
  • [6] Pneumococcal vaccine response in human immunodeficiency virus-infected patients
    Swiatlo, E
    Benton, K
    Briles, DE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (03): : 777 - 777
  • [7] Prognostic Factors of Human Immunodeficiency Virus-Infected Patients on Chronic Hemodialysis
    Laranjinha, Ivo
    Matias, Patricia Joao
    Dickson, Jorge
    Estibeiro, Herminia
    Boquinhas, Helena
    Barata, Jose Diogo
    [J]. BLOOD PURIFICATION, 2017, 44 (03) : 244 - 250
  • [8] 3 Cases of Systemic Strongyloides in Human Immunodeficiency Virus-Infected Patients
    Lumsden, Sarah
    Hemmige, Vagish
    Woc-Colburn, Laila
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2018, 26 (03) : 150 - 153
  • [9] Lipodystrophy in human immunodeficiency virus-infected patients
    Chen, DL
    Misra, A
    Garg, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11): : 4845 - 4856
  • [10] Hyperhomocysteinemia in human immunodeficiency virus-infected patients
    Duro, M.
    Manso, M. C.
    Rebelo, I
    Medeiros, R.
    Almeida, C.
    [J]. BIOMEDICAL RESEARCH-INDIA, 2016, 27 (02): : 557 - 562